🔴 Tvardi Therapeutics is trading 5.66% down in pre-market with no clear company-specific catalyst identified

Tvardi Therapeutics is trading at $1.00, down 5.66% in pre-market; no clear company-specific catalyst for the decline was identified.

• The company’s latest listed release is dated September 24, 2026.
• Nasdaq futures were down 0.58%, while Dow futures were up 0.55%; this does not establish a cause for the stock’s move.
• Shares pulled back after closing at $1.06 on October 12; no reliable volume or trading-activity figure was provided.